Highest-materiality recent filing
Exponent Q2 rev up 12% (ex-reimb), EPS $0.60 vs $0.52; raises FY guidance, boosts buyback by $50M
Q2 revenues before reimbursements $148.9M (+12% YoY); net income $29.4M ($0.60 diluted EPS) vs $26.6M ($0.52).
Exponent Q1 revenue up 14% to $166.3M; EPS $0.59; declares $0.31 dividend, adds $50M buyback
Revenue before reimbursements $151.8M (+10% YoY); net income $29.6M ($0.59 diluted EPS) vs $26.7M ($0.52).
Exponent appoints John Pye as President, Eric Anderson as CFO; Paul Johnston retiring
John Pye appointed President effective May 1, 2026; base salary $650,000; receives 21,000 stock options vesting over 4 years.
Exponent Q4 revenue $147.4M (+7.8%), EPS $0.49; FY revenue $582M; dividend raised to $0.31
Q4 total revenues $147.4M, up 7.8% YoY; net income $24.8M, diluted EPS $0.49 vs $0.46.
Exponent Q3 net revenue up 10% YoY; raises FY2025 margin guidance; adds $100M buyback
Total revenue $147.1M; revenues before reimbursements up 10% to $137.1M; net income $28.0M ($0.55 EPS) vs $26.0M ($0.50 EPS) a year ago.
Exponent Q2 EPS $0.52 vs $0.57 YoY; revenues flat, guides Q3 mid-single digit growth
Diluted EPS $0.52 (down from $0.57); net income $26.6M vs $29.2M in Q2 2024.
Exponent Q1 revenue flat at $145.5M; EPS down to $0.52; Q2 revenue guided down low-single digits
Total revenues flat at $145.5M; revenues before reimbursements flat at $137.4M YoY.
Exponent Q4 rev up 11% to $136.8M; EPS $0.46; div raised to $0.30
Q4 net income $23.6M ($0.46 diluted EPS) vs $20.9M ($0.41) a year ago; rev before reimb $123.8M (+8.7%).
Exponent Q3 net income up 6% to $0.50 EPS; revenue flat; raises FY EBITDA margin guidance
Q3 revenues before reimbursements $125.1M (flat YoY); net income $26.0M (+6%, $0.50 diluted EPS vs $0.48).
Exponent Q2 net income up 14% to $0.57 EPS; raises full-year guidance
Q2 net income $29.2M ($0.57 EPS) up 14% YoY; revenue flat at $140.5M.
Exponent Q1 revs before reimbursements up 6.6% to $137.2M, EPS $0.59, raises FY guidance
Total revenues $144.9M (+3.3% YoY); net income $30.1M ($0.59 diluted EPS) vs $29.1M ($0.56).
Exponent Q4 net income down to $0.41 EPS; raises dividend to $0.28, adds $61.6M buyback
Q4 revenues before reimbursements $113.9M (+1.1% YoY); net income $20.9M ($0.41 diluted EPS) vs $22.5M ($0.44) prior year.
Q3 revenues before reimbursements $125.0M (+9% YoY); net income $24.5M ($0.48 diluted EPS) vs $24.4M ($0.47) prior year.
Exponent Q2 rev before reimb +9.7% to $129.7M, EPS $0.50; FY guidance maintained
Total revenues $140.2M (+7.6% YoY); revenues before reimbursements $129.7M (+9.7% YoY).
Exponent Q1 revenues $140.3M (+9.2% YoY), EPS $0.56; reiterates FY23 guidance
Revenues before reimbursements $128.7M, up 9.2% YoY; net income $29.1M, diluted EPS $0.56 (incl. $0.07 tax benefit).
Exponent Q4 revenue up 12%, net income $22.5M; raises dividend to $0.26/share
Q4 total revenues $127.4M (+12.2% YoY); revenues before reimbursements $112.6M (+7.9%).
Exponent reports Q3 revenue up 6.2%, net income flat; narrows FY22 guidance, declares $0.24 dividend
Q3 revenue before reimbursements $115.1M (+6.2% YoY); total revenues $127.2M (+9.3% YoY).
Exponent Q2 revenue $130.3M (+8.7% YoY), EPS $0.49; declares $0.24 quarterly dividend
Q2 total revenues $130.3M (+8.7% YoY), net revenues $118.2M (+5.1%); diluted EPS $0.49 vs $0.48.
Revenue before reimbursements $117.9M (+7.6% YoY); total revenue $128.5M (+10.3%).
Exponent increases share repurchase authorization by $150M to $179.5M total available
Board authorized additional $150M share repurchase, bringing total authorization to $179.5M.
Q4 2021 revenues before reimbursements $104.3M (+7.2% YoY); net income $20.4M ($0.38 diluted EPS) vs $21.8M ($0.41) in Q4 2020.
Exponent Q3 net revenue up 16% to $108.5M; EPS $0.46 vs $0.34; EBITDA margin 31.4% vs 27.8%
Q3 FY2021 net income $24.6M ($0.46 diluted EPS) vs $18.1M ($0.34) in Q3 2020.
Exponent Q2 net rev $112.5M (+28% YoY), EPS $0.48; declares $0.20 dividend; raises FY outlook
Net revenues before reimbursements up 28% YoY to $112.5M; net income $25.4M vs $16.3M.
On October 28, 2024, Eric Guyer, Ph.D. tendered his resignation, effective November 8, 2024, from his role as Group Vice President of Exponent, Inc.
On February 26, 2024, Exponent, Inc. (the “Company”) appointed Brian Kundert as Chief Human Resources Officer, effective March 16, 2024.
On February 2, 2024, Exponent, Inc. announced that Sally Shepard will be retiring from her role as its Chief Human Resources Officer, effective March 15, 2024.
On October 2, 2023, Steven J. Murray, Ph.D. tendered his resignation, effective October 13, 2023, from his role as Group Vice President of Exponent, Inc.
On February 15, 2023, Exponent, Inc.’s (the “Company”) Board of Directors (the “Board”) increased its size from six to seven members and appointed Karen Richardson to the Board.
Max materiality 0.75 · Median 0.62 · Most common event earnings